Chester County News and Community Website
Do you love keeping track of what’s going on in Chester County? Put your knowledge and expertise to use as a MyChesCo community contributor. Learn more >>
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) reported third-quarter financial results and detailed a series of strategic and regulatory milestones that collectively secured more than $147 million …
Orchestra BioMed’s Big Cash Infusion Sets Stage for High-Stakes Cardiology Trials Read More
HARRISBURG, PA — A former McKeesport detective who once oversaw the finances of Fraternal Order of Police Lodge 91 will serve jail time after admitting he siphoned nearly $1 million …
Former PA Detective Sentenced in Shocking $1M Police Lodge Theft Scheme Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) reported third-quarter financial results and said it is preparing to submit a New Drug Application (NDA) for its lead candidate, lorundrostat, by …
Mineralys Nears Pivotal FDA Filing as Hypertension Drug Lorundrostat Advances Read More
YEADON, PA — Philly’s Best Steak Company is stepping into its next chapter with a sharp new brand identity, renewed messaging, and ambitious expansion plans—while insisting the product that built …
Philly’s Best Unveils Bold Rebrand as It Prepares for Major Expansion Read More
PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. announced it will present interim clinical data from its first-in-human Phase 1 study of VIPER-101, a CD5-modulated autologous CAR-T therapy, at the upcoming American …
New CAR-T Data Could Upend T-Cell Lymphoma Care — Vittoria Prepares First Reveal Read More
HARRISBURG, PA — The owner of a Pittsburgh towing company pleaded guilty to a sweeping scheme built on hidden fees, inflated invoices, and sky-high “accident services” charges that prosecutors say …
PA Towing Boss Faces Massive Restitution in Predatory Billing Scandal Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) reported third-quarter financial results and outlined major clinical milestones that position the company for a pivotal two-year stretch focused on advancing …
ArriVent Maps Ambitious 2026 Oncology Push as Firmonertinib Program Gains Steam Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) unveiled compelling new data from its Phase 2 study of VP-315, a first-in-class oncolytic peptide immunotherapy, showing strong local immune activation …
New Cancer Data Hints at a Surgery-Free Future — Verrica’s VP-315 Shows Big Promise Read More
PHILADELPHIA, PA — Federal prosecutors said Monday that a Maryland man admitted to sending a barrage of threatening letters to synagogues and Jewish institutions across several states, concluding a sprawling …
Wave of Threats to Jewish Groups Sparks Guilty Plea in Multi-State Case Read More
WILMINGTON, DE — AstraZeneca reported statistically significant Phase III results showing that Fasenra (benralizumab) can substantially delay disease worsening for patients with hypereosinophilic syndrome (HES), a rare and potentially life-threatening …
AstraZeneca’s Fasenra Shows Major Breakthrough in Delaying HES Disease Flares Read More